Instalab

Kiwi (Act d 10) IgE Test Blood

Pinpoint whether your kiwi reactions come from a protein linked to more serious, body-wide allergic responses.

Should you take a Kiwi (Act d 10) IgE test?

This test is most useful if any of these apply to you.

Reacting to Kiwi
You have had mouth tingling, hives, stomach upset, or worse after eating kiwi and want to know which specific protein is driving the reaction.
Sensitive to Multiple Plant Foods
You react to several seeds, nuts, or stone fruits and want to check whether a shared protein family is behind the pattern.
Had an Unexplained Allergic Reaction
You had a body-wide allergic episode and want to investigate whether a kiwi protein in the LTP family could be a contributor.
Building a Detailed Allergy Profile
You already know you have food allergies and want component-level resolution to understand cross-reactivity risk beyond a basic panel.

About Kiwi (Act d 10) IgE

If you have ever felt your mouth tingle, your skin flare, or your stomach turn after eating kiwi, the next useful question is which protein inside the fruit your immune system is reacting to. Not all kiwi allergies behave the same way, and the specific protein involved can shape whether you tend to get mild mouth symptoms or something that spreads through your whole body.

This test looks at one of those proteins in particular: Act d 10, a nonspecific lipid transfer protein found in kiwi seeds. Knowing whether your antibodies target this protein helps you understand your sensitization pattern, which matters for how cautious you need to be around kiwi and certain related foods.

What This Test Actually Measures

This blood test measures IgE (immunoglobulin E), the class of antibody your immune system makes when it treats a harmless substance as a threat. Specifically, it measures IgE directed at Act d 10, one of thirteen known kiwi proteins that can trigger allergic reactions. Act d 10 belongs to a family called nonspecific lipid transfer proteins (LTPs), which are small, sturdy proteins found in the seeds and skins of many plants.

LTPs are notable because they often survive heat and digestion, which means reactions to them are more likely to involve the whole body rather than just the mouth. They also tend to cross-react across plant foods, so sensitization to one LTP can sometimes signal sensitivity to LTPs in other foods like peach, peanut, or tree nuts. This test does not tell you whether you will react clinically, only whether your immune system has produced antibodies against this particular kiwi protein.

Why Kiwi Allergy Is Not a Single Disease

Kiwi allergy comes in several distinct patterns, and the protein driving your reaction shapes how it behaves. Some people react primarily to Act d 1, a major kiwi protein linked to more severe, isolated kiwi allergy. Others react to Act d 8, a protein closely related to birch pollen that usually causes milder, mouth-focused symptoms tied to pollen-food allergy syndrome. Act d 10 sensitization fits a third pattern, the LTP-type, which can carry a higher risk of body-wide reactions and cross-reactivity with other LTP-containing plant foods.

Where you live also matters. In a study of 311 kiwi-allergic patients across Europe, sensitization to Act d 10 was found in about 22% of patients in southern Europe, where LTP sensitization is generally more common. In other regions, Act d 1 or Act d 8 patterns dominate instead. The takeaway: a single "kiwi allergy" diagnosis hides several different immune profiles, and knowing your profile changes how you should think about your risk.

Severity, LTP Sensitization, and What It Suggests

Act d 10 is generally classified as a minor kiwi allergen in terms of how often it shows up overall, but its biology matters. LTPs are heat-stable and digestion-resistant proteins linked in other foods (like peach and peanut) to systemic, sometimes severe, allergic reactions. Researchers studying kiwi allergy have flagged Act d 10 as part of this LTP-syndrome pattern, where reactions are more likely to extend beyond the mouth.

Honest framing of the evidence: while researchers describe Act d 10 as part of a pattern associated with more systemic reactions, IgE levels to kiwi (including individual components) do not reliably predict how severe your reactions will be. A high number does not guarantee a bad reaction, and a low number does not guarantee safety. The clinical history of what actually happens when you eat kiwi remains the most informative piece of information, with this test adding context about which immune pathway is involved.

Why a Standard Kiwi Allergy Test Can Miss This

Most people who get tested for kiwi allergy receive a skin prick test or a blood test that measures IgE to whole kiwi extract. These approaches have real limitations. In a large European study, a skin prick test with extract caught only about 20% of kiwi-allergic patients, while ImmunoCAP testing with whole kiwi extract caught about 46%. Adding component testing for six individual proteins (including Act d 10) increased sensitivity to 65%.

What that means in plain terms: a standard kiwi test can come back negative or unclear, even when your immune system is reacting to a specific kiwi protein. Component testing for individual proteins like Act d 10 is what reveals which protein is driving the reaction, and that distinction shapes whether you are dealing with an oral-only pattern, a pollen-related pattern, or an LTP pattern with potentially broader food cross-reactivity.

Cross-Reactivity With Other Foods

If your test shows IgE against Act d 10, the relevant context is the broader family of LTP proteins in other plant foods. LTPs are found in foods like peach, hazelnut, walnut, and peanut, and people sensitized to one LTP can sometimes react to LTPs in unrelated foods. This is part of what allergists call LTP syndrome.

A positive Act d 10 result does not automatically mean you will react to all LTP-containing foods. But it does raise the question of whether other LTP sensitizations are worth investigating, especially if you have had unexplained reactions to nuts, seeds, or stone fruits. Discussing the result alongside your overall food history is more useful than reading it in isolation.

Tracking Your Trend

A single IgE measurement is a snapshot, and IgE values can shift over time, especially in children whose immune systems are still maturing. Researchers studying biological variation in lab tests recommend personalized reference ranges based on multiple measurements, because within-person variability often makes a single reading an imperfect picture of your typical level.

For Act d 10 IgE specifically, the literature does not give exact figures for how much the number bounces around within one person over time, but the general principle applies. If your initial result is positive and meaningful to your situation, retesting at intervals helps confirm whether sensitization is stable, rising, or fading. A reasonable approach is to get a baseline, then retest at 6 to 12 months if you are tracking changes, or sooner if your symptoms shift dramatically. Trend matters more than any single number.

What to Do With an Unexpected Result

A positive Act d 10 IgE result is not a diagnosis on its own. It tells you your immune system has produced antibodies to this kiwi protein. Whether that translates into clinical allergy depends on what actually happens when you eat kiwi or related foods. The decision pathway looks like this: if you have a clear history of reactions plus a positive result, the picture is straightforward, and avoiding kiwi (and likely related LTP foods) is reasonable until you discuss formal testing with an allergist.

If the result is positive but you have eaten kiwi without obvious problems, the situation needs interpretation. Sensitization without clinical reaction is well documented in allergy testing. The next step is usually a conversation with an allergist who can put the result in context, potentially order companion component tests (Act d 1, Act d 8, and others), and decide whether an oral food challenge is warranted. The challenge remains the gold standard for confirming or ruling out true food allergy. Do not assume a positive number alone means you must permanently avoid a food, and do not assume a negative number means you can ignore symptoms you actually experience.

When Results Can Be Misleading

A few realities affect how to read a single Act d 10 IgE result:

  • IgE level does not equal severity: research consistently shows that the size of the IgE number does not reliably predict how severe a reaction will be. Use the result for pattern recognition, not as a severity score.
  • A negative does not rule out kiwi allergy: people can react to other kiwi proteins (Act d 1, Act d 8, Act d 9, Act d 12, Act d 13) even if Act d 10 IgE is undetectable. The right interpretation depends on which components were tested.
  • Sensitization is not the same as allergy: having detectable IgE means your immune system has noticed the protein. It does not guarantee you will react clinically. Clinical history is essential context.
  • Geography and history shape interpretation: Act d 10 sensitization is more common in some populations than others. Where you live, what foods you eat regularly, and your family history all inform how seriously to weigh the result.

How This Fits Into a Broader Allergy Workup

Act d 10 IgE is most informative when read alongside other kiwi components and your overall allergy profile. A full picture often includes IgE to other kiwi proteins (Act d 1, Act d 8, Act d 9, and seed proteins Act d 12 and Act d 13), total IgE, and sometimes IgE to other LTP-containing foods if cross-reactivity is suspected. Skin prick testing with fresh kiwi can complement blood testing, and an oral food challenge under medical supervision remains the most definitive way to confirm clinical reactivity when needed.

Frequently Asked Questions

References

15 studies
  1. Bringheli I, Brindisi G, Morelli R, Marchetti L, Cela L, Gravina a, Pastore F, Semeraro a, Cinicola B, Capponi M, Gori a, Pignataro E, Piccioni M, Zicari a, Anania CNutrients2023
  2. Le T, Bublin M, Breiteneder H, Fernández-rivas M, Asero R, Ballmer-weber B, Barreales L, Bures P, Belohlavkova S, De Blay F, Clausen M, Dubakiene R, Gíslason D, Van Hoffen E, Jędrzejczak-czechowicz M, Kowalski M, Kralimarkova T, Lidholm J, Dewitt AM, Mills C, Papadopoulos N, Popov TA, Purohit a, Van Ree R, Seneviratne S, Sinaniotis a, Summers C, Vázquez-cortes S, Vieths S, Vogel L, Hoffmann-sommergruber K, Knulst aThe Journal of Allergy and Clinical Immunology2012
  3. Bublin M, Pfister M, Radauer C, Oberhuber C, Bulley S, Dewitt AM, Lidholm J, Reese G, Vieths S, Breiteneder H, Hoffmann-sommergruber K, Ballmer-weber BThe Journal of Allergy and Clinical Immunology2010
  4. Carlson G, Coop CAnnals of Allergy, Asthma & Immunology2019
  5. Nilsson C, Brostedt P, Hidman J, Odijk J, Borres M, Sjölander S, Englund HPediatric Allergy and Immunology2015